SBC Medical Group (SBC) Competitors

SBC Medical Group logo
$6.12 -0.06 (-0.97%)
Closing price 04:00 PM Eastern
Extended Trading
$6.10 -0.02 (-0.33%)
As of 04:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SBC vs. AGL, ASTH, WGS, LMRI, and AMN

Should you buy SBC Medical Group stock or one of its competitors? SBC Medical Group's main competitors and comparable companies include Agilon Health (AGL), Astrana Health (ASTH), GeneDx (WGS), Lumexa Imaging (LMRI), and AMN Healthcare Services (AMN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does SBC Medical Group compare to Agilon Health?

Agilon Health (NYSE:AGL) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, media sentiment, valuation, risk, analyst recommendations and institutional ownership.

SBC Medical Group has a net margin of 27.99% compared to Agilon Health's net margin of -1.45%. SBC Medical Group's return on equity of 18.47% beat Agilon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Agilon Health-1.45% -51.97% -7.15%
SBC Medical Group 27.99%18.47%13.10%

60.8% of SBC Medical Group shares are held by institutional investors. 2.5% of Agilon Health shares are held by company insiders. Comparatively, 81.7% of SBC Medical Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Agilon Health currently has a consensus price target of $107.38, indicating a potential downside of 6.49%. SBC Medical Group has a consensus price target of $10.00, indicating a potential upside of 63.16%. Given SBC Medical Group's stronger consensus rating and higher possible upside, analysts plainly believe SBC Medical Group is more favorable than Agilon Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Agilon Health
2 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.44
SBC Medical Group
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, SBC Medical Group had 17 more articles in the media than Agilon Health. MarketBeat recorded 24 mentions for SBC Medical Group and 7 mentions for Agilon Health. Agilon Health's average media sentiment score of 0.93 beat SBC Medical Group's score of 0.62 indicating that Agilon Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Agilon Health
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
SBC Medical Group
7 Very Positive mention(s)
2 Positive mention(s)
10 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Agilon Health has a beta of 3.1, suggesting that its stock price is 210% more volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market.

SBC Medical Group has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agilon Health$5.93B0.33-$391.35M-$5.55N/A
SBC Medical Group$173.61M3.63$50.99M$0.5012.26

Summary

SBC Medical Group beats Agilon Health on 12 of the 17 factors compared between the two stocks.

How does SBC Medical Group compare to Astrana Health?

SBC Medical Group (NASDAQ:SBC) and Astrana Health (NASDAQ:ASTH) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, risk, earnings, profitability, analyst recommendations and valuation.

In the previous week, SBC Medical Group had 21 more articles in the media than Astrana Health. MarketBeat recorded 24 mentions for SBC Medical Group and 3 mentions for Astrana Health. SBC Medical Group's average media sentiment score of 0.62 beat Astrana Health's score of 0.61 indicating that SBC Medical Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SBC Medical Group
7 Very Positive mention(s)
2 Positive mention(s)
10 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Astrana Health
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

60.8% of SBC Medical Group shares are owned by institutional investors. Comparatively, 52.8% of Astrana Health shares are owned by institutional investors. 81.7% of SBC Medical Group shares are owned by company insiders. Comparatively, 20.3% of Astrana Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

SBC Medical Group has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market. Comparatively, Astrana Health has a beta of 1.18, meaning that its share price is 18% more volatile than the broader market.

SBC Medical Group presently has a consensus price target of $10.00, suggesting a potential upside of 63.16%. Astrana Health has a consensus price target of $50.38, suggesting a potential upside of 56.82%. Given SBC Medical Group's higher probable upside, equities analysts clearly believe SBC Medical Group is more favorable than Astrana Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SBC Medical Group
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Astrana Health
0 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.80

SBC Medical Group has higher earnings, but lower revenue than Astrana Health. SBC Medical Group is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SBC Medical Group$173.61M3.63$50.99M$0.5012.26
Astrana Health$3.91B0.46$22.49M$1.0730.02

SBC Medical Group has a net margin of 27.99% compared to Astrana Health's net margin of 1.36%. SBC Medical Group's return on equity of 18.47% beat Astrana Health's return on equity.

Company Net Margins Return on Equity Return on Assets
SBC Medical Group27.99% 18.47% 13.10%
Astrana Health 1.36%11.57%4.17%

Summary

SBC Medical Group beats Astrana Health on 10 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to GeneDx?

GeneDx (NASDAQ:WGS) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation, profitability and media sentiment.

GeneDx currently has a consensus price target of $90.14, indicating a potential upside of 93.86%. SBC Medical Group has a consensus price target of $10.00, indicating a potential upside of 63.16%. Given GeneDx's stronger consensus rating and higher possible upside, equities research analysts clearly believe GeneDx is more favorable than SBC Medical Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GeneDx
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.67
SBC Medical Group
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, SBC Medical Group had 16 more articles in the media than GeneDx. MarketBeat recorded 24 mentions for SBC Medical Group and 8 mentions for GeneDx. SBC Medical Group's average media sentiment score of 0.62 beat GeneDx's score of 0.55 indicating that SBC Medical Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GeneDx
1 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
SBC Medical Group
7 Very Positive mention(s)
2 Positive mention(s)
10 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

SBC Medical Group has a net margin of 27.99% compared to GeneDx's net margin of -24.10%. SBC Medical Group's return on equity of 18.47% beat GeneDx's return on equity.

Company Net Margins Return on Equity Return on Assets
GeneDx-24.10% 1.98% 1.02%
SBC Medical Group 27.99%18.47%13.10%

GeneDx has a beta of 2, meaning that its share price is 100% more volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market.

61.7% of GeneDx shares are owned by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are owned by institutional investors. 25.2% of GeneDx shares are owned by insiders. Comparatively, 81.7% of SBC Medical Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

SBC Medical Group has lower revenue, but higher earnings than GeneDx. GeneDx is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GeneDx$427.54M3.24-$21.02M-$3.78N/A
SBC Medical Group$173.61M3.63$50.99M$0.5012.26

Summary

SBC Medical Group beats GeneDx on 10 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to Lumexa Imaging?

SBC Medical Group (NASDAQ:SBC) and Lumexa Imaging (NASDAQ:LMRI) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, valuation and risk.

In the previous week, SBC Medical Group had 3 more articles in the media than Lumexa Imaging. MarketBeat recorded 24 mentions for SBC Medical Group and 21 mentions for Lumexa Imaging. Lumexa Imaging's average media sentiment score of 0.68 beat SBC Medical Group's score of 0.62 indicating that Lumexa Imaging is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SBC Medical Group
7 Very Positive mention(s)
2 Positive mention(s)
10 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Lumexa Imaging
5 Very Positive mention(s)
4 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

SBC Medical Group has a net margin of 27.99% compared to Lumexa Imaging's net margin of -1.96%. SBC Medical Group's return on equity of 18.47% beat Lumexa Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
SBC Medical Group27.99% 18.47% 13.10%
Lumexa Imaging -1.96%-2.93%-0.99%

SBC Medical Group currently has a consensus target price of $10.00, suggesting a potential upside of 63.16%. Lumexa Imaging has a consensus target price of $17.60, suggesting a potential upside of 20.88%. Given SBC Medical Group's higher probable upside, equities research analysts clearly believe SBC Medical Group is more favorable than Lumexa Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SBC Medical Group
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Lumexa Imaging
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
3.00

SBC Medical Group has higher earnings, but lower revenue than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SBC Medical Group$173.61M3.63$50.99M$0.5012.26
Lumexa Imaging$267.73M5.22-$47.10M-$0.54N/A

60.8% of SBC Medical Group shares are held by institutional investors. 81.7% of SBC Medical Group shares are held by insiders. Comparatively, 0.7% of Lumexa Imaging shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

SBC Medical Group beats Lumexa Imaging on 10 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to AMN Healthcare Services?

SBC Medical Group (NASDAQ:SBC) and AMN Healthcare Services (NYSE:AMN) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings.

60.8% of SBC Medical Group shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 81.7% of SBC Medical Group shares are owned by company insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

SBC Medical Group currently has a consensus price target of $10.00, indicating a potential upside of 63.16%. AMN Healthcare Services has a consensus price target of $39.17, indicating a potential upside of 1.68%. Given SBC Medical Group's stronger consensus rating and higher possible upside, equities research analysts clearly believe SBC Medical Group is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SBC Medical Group
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
AMN Healthcare Services
1 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.33

In the previous week, SBC Medical Group had 17 more articles in the media than AMN Healthcare Services. MarketBeat recorded 24 mentions for SBC Medical Group and 7 mentions for AMN Healthcare Services. SBC Medical Group's average media sentiment score of 0.62 beat AMN Healthcare Services' score of 0.48 indicating that SBC Medical Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SBC Medical Group
7 Very Positive mention(s)
2 Positive mention(s)
10 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
AMN Healthcare Services
2 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

SBC Medical Group has a net margin of 27.99% compared to AMN Healthcare Services' net margin of 3.10%. AMN Healthcare Services' return on equity of 23.42% beat SBC Medical Group's return on equity.

Company Net Margins Return on Equity Return on Assets
SBC Medical Group27.99% 18.47% 13.10%
AMN Healthcare Services 3.10%23.42%7.19%

SBC Medical Group has higher earnings, but lower revenue than AMN Healthcare Services. SBC Medical Group is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SBC Medical Group$173.61M3.63$50.99M$0.5012.26
AMN Healthcare Services$2.73B0.54-$95.70M$2.7514.01

SBC Medical Group has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.42, suggesting that its share price is 58% less volatile than the broader market.

Summary

SBC Medical Group beats AMN Healthcare Services on 10 of the 16 factors compared between the two stocks.

Get SBC Medical Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SBC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SBC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SBC vs. The Competition

MetricSBC Medical GroupHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$629.44M$10.57B$7.74B$11.62B
Dividend YieldN/A2.54%2.46%4.43%
P/E Ratio12.2435.7734.1629.83
Price / Sales3.632.088.485.62
Price / Cash10.2123.3421.9322.50
Price / Book2.383.594.373.66
Net Income$50.99M$332.46M$3.52B$392.18M
7 Day Performance15.69%-4.03%-5.43%-4.26%
1 Month Performance18.60%-1.76%-4.54%-6.73%
1 Year Performance101.32%18.97%-1.42%-7.08%

SBC Medical Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SBC
SBC Medical Group
4.0672 of 5 stars
$6.12
-1.0%
$10.00
+63.4%
+86.7%$629.44M$173.61M12.24863
AGL
Agilon Health
1.5447 of 5 stars
$114.68
+1.0%
$102.25
-10.8%
+715.9%$1.93B$5.93BN/A856
ASTH
Astrana Health
3.414 of 5 stars
$32.94
+2.4%
$50.38
+52.9%
+52.7%$1.84B$3.91B30.813,000
WGS
GeneDx
3.0007 of 5 stars
$55.31
+0.9%
$90.14
+63.0%
-60.2%$1.65B$427.54MN/A1,300
LMRI
Lumexa Imaging
3.9607 of 5 stars
$15.99
+14.9%
$16.80
+5.1%
N/A$1.53B$267.73MN/A5,019

Related Companies and Tools


This page (NASDAQ:SBC) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners